Literature DB >> 25119250

The toxicology investigators consortium case registry-the 2013 experience.

Sean H Rhyee1, Lynn Farrugia, Timothy Wiegand, Eric A Smith, Paul M Wax, Jeffrey Brent.   

Abstract

The Toxicology Investigators Consortium (ToxIC) Case Registry was established in 2010 by the American College of Medical Toxicology. The Registry includes all medical toxicology consultations performed at participating sites. This report summarizes the Registry data for 2013. A query of the ToxIC Registry was carried out for the dates of January 1 through December 31, 2013. Specific data reviewed for analysis included demographics (age, gender), source of consultation, reasons for consultation, agents involved in toxicological exposures, signs, symptoms and clinical findings, and treatment. A total of 8,598 cases were entered into the Registry in 2013. Females accounted for 49.2 % of cases, males for 47.7 %, and gender was not reported in 3.1 %. The majority of patients (63.4 %) were adults between the ages of 19 and 65 years. There were 93 fatalities (1.1 %). Most referrals for medical toxicology consultation originated from the emergency department (59.7 %) or inpatient services (16.7 %). Exposures to pharmaceutical products (intentional and unintentional) made up 50.0 % of cases. Illicit drug abuse (8.0 %) and adverse drug reactions (ADRs) (4.8 %) were the next most frequent reasons for consultation. Similar to past years, nonopioid analgesics, sedative-hypnotics, and opioids were the most commonly encountered agents. Symptoms or clinical findings were documented in 71.1 % of patients. Of all cases, 54.6 % required some form of medical treatment (antidotes, antivenom, chelation, specific types of supportive care). This report serves as a comprehensive survey of medical toxicology practice within participating institutions. Prior trends continued to apply this year and indicate analgesic (opioid and nonopioid), sedative-hypnotic/muscle relaxant agents, illicit drug use, and ADRs continue to be major toxicological problems. Cases requiring medical toxicology consultation in 2013 predominantly involved pharmaceuticals and illicit drugs. Reasons for these drug exposures were diverse and included intentional overdose, unintentional exposure, withdrawal syndromes, and ADRs. Nonopioid analgesics, sedative-hypnotic agents, and opioids remained the most frequently encountered agent classes. While over half of cases required some form of medical treatment, fatalities were uncommon.

Entities:  

Mesh:

Year:  2014        PMID: 25119250      PMCID: PMC4252290          DOI: 10.1007/s13181-014-0417-0

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  4 in total

1.  The Toxicology Investigators Consortium (ToxIC) Registry.

Authors:  Paul M Wax; Kurt C Kleinschmidt; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2011-12

2.  The Toxicology Investigators Consortium Case Registry-the 2010 experience.

Authors:  Jeffrey Brent; Paul M Wax; Tayler Schwartz; Kurt C Kleinschmidt; Kristin Engebretsen; Michael Beuhler
Journal:  J Med Toxicol       Date:  2011-12

3.  The Toxicology Investigators Consortium Case Registry--the 2012 experience.

Authors:  Timothy Wiegand; Paul Wax; Eric Smith; Katherine Hart; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2013-12

4.  The Toxicology Investigators Consortium Case Registry--the 2011 experience.

Authors:  Timothy J Wiegand; Paul M Wax; Tayler Schwartz; Yaron Finkelstein; Rachel Gorodetsky; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2012-12
  4 in total
  8 in total

1.  The Toxicology Investigators Consortium Case Registry--the 2014 Experience.

Authors:  Sean H Rhyee; Lynn Farrugia; Sharan L Campleman; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2015-12

2.  Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC).

Authors:  G S Wang; R Levitan; T J Wiegand; J Lowry; R F Schult; S Yin
Journal:  J Med Toxicol       Date:  2016-03

3.  The Toxicology Investigators Consortium Case Registry-the 2017 Annual Report.

Authors:  Lynn A Farrugia; Sean H Rhyee; Sharan L Campleman; Bryan Judge; Louise Kao; Anthony Pizon; Lauren Porter; Anne M Riederer; Timothy Wiegand; Diane Calello; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2018-08-09

Review 4.  The Toxicology Investigators Consortium Case Registry-the 2015 Experience.

Authors:  Lynn A Farrugia; Sean H Rhyee; Sharan L Campleman; Anne-Michelle Ruha; Timothy Weigand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2016-08-12

5.  The Toxicology Investigators Consortium Case Registry-the 2016 Experience.

Authors:  Lynn A Farrugia; Sean H Rhyee; Diane P Calello; Sharan L Campleman; Anne M Riederer; Hannah R Malashock; Anthony Pizon; Timothy Wiegand; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2017-08-01

6.  The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report.

Authors:  Meghan B Spyres; Lynn A Farrugia; A Min Kang; Diane P Calello; Sharan L Campleman; Anthony Pizon; Timothy Wiegand; Louise Kao; Brad D Riley; Shao Li; Paul M Wax; Jeffery Brent
Journal:  J Med Toxicol       Date:  2019-10-22

7.  Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.

Authors:  Sarah Ann R Anderson; Anna M Oprescu; Diane Calello; Andrew Monte; Peter S Dayan; Yasmin L Hurd; Alex F Manini
Journal:  Pediatrics       Date:  2019-07-08       Impact factor: 7.124

8.  Clinical characteristics and time trends of hospitalized methadone exposures in the United States based on the Toxicology Investigators Consortium (ToxIC) case registry: 2010-2017.

Authors:  Omid Mehrpour; Christopher Hoyte; Alireza Amirabadizadeh; Jeffrey Brent
Journal:  BMC Pharmacol Toxicol       Date:  2020-07-22       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.